Medtronic Vs Stryker: Which is a Better Buy?

PUBLISHED Jun 18, 2024, 1:07:50 PM        SHARE

img
imgNoah Brody

What is the #1 medical device company?

According to MDDIonline, the largest medical device company in terms of revenue is Medtronic plc. Medtronic is a medical device manufacturer based out of Minneapolis, Minnesota. They were founded in Ireland in 1949, and have become a major player in the medical device field. Their revenue for 2023 was $31.56 billion. This narrowly edged out Abbott Laboratories, Danaher Corporation, and Johnson & Johnson. While some of these are more well known household names, Medtronic has actually been the top medical device manufacturer since 2017.

Their hold on the highest revenue in the segment is due to their innovative approach to patient care. In 2023, Medtronic and NVidia introduced a plan to use AI to assist in connected care. They have also been at the forefront of treatment for more than 70 health conditions from diabetes to cardiovascular disease. In recent times, another midwest-based medical device company has been making waves, and that is Stryker Corporation. The Kalamazoo, Michigan based company has entered the top 10 largest medical device companies. Their growth in recent years has led many to question; what is the better buy?

The Case for Stryker

As mentioned previously, Stryker is an American manufacturer of medical devices. They are based out of Kalamazoo, Michigan. Last year, they had revenue of $20.49 billion, the highest in the company’s history, and an 11% increase over 2022. This continues their very strong performance over the past 5 years, as they have seen quarterly growth every single quarter since June 2020, and that was the only time since 2010 that they have not experienced quarterly growth. They have continued to see steady revenue growth, only ever halted by the Covid-19 pandemic.

The continued and consistent increase in the revenue for Stryker is reflected in the stock price. No matter how you look at it, or which time frame, the performance for Stryker has been impressive. Year-to-date the stock price is up over 13%, and over the last full year is up 23%. Also of note is the dividend. They have increased their dividend each year since 1994, further cementing them as a strong stock to consider.

Medtronic’s “Shaky Standing”?

While yes, Medtronic is still the largest medical device manufacturer, there are some who believe there is less potential reward there. While their revenue has been high, there has been very little growth. In fact, their trailing 12 month revenue has ranged between $27.8 billion and $32.3 billion each report since 2016. While Stryker had only one quarter of failing to increase revenue since 2010, in the same time frame, Medtronic has failed to do so 13 times.

When diving into the stock for Medtronic, things remain unclear. While over the past year there has been an increase to Medtronic’s stock price, it has only increased 1.02%. Year-to-date performance is not impressive, falling 0.66%. The largest concern, however, is on the long-term outlook for Medtronic. Over the past 5 years, they have experienced and 11.11% decrease in the price of their stock. During this same window. Stryker has increased over 80%%. Medtronic does, however, have an impressive record of increasing their dividend share. For 47 consecutive years, they have increased the dividend per share, now reaching a yield of 3.35% and annual dividend of $2.76 per share.

There is reason to believe revenue and stock price growth may be on the horizon. Recent progress with their cardiovascular division offers promise of larger revenues in the coming years, while the impact of Covid-19 lessens with each passing year. Stryker

Which Stock Should You Buy?

While the numbers certainly look impressive for Stryker, and less so for Medtronic, the answer to this question is not so simple. It is unlikely that Stryker will continue to increase their revenue by 8+% per year. This will lead to a slowing of the increase in their stock price at some time in the future. At the current traded price of $335.54, how much higher can this stock price climb? Medtronic has been a major player in the segment for decades, and has been the highest revenue company in the field for a decade. Their current traded price of $82.29 comes despite hitting an all-time high in 2021 and failing to match that revenue in the time following. Also noteworthy is the greater FCF margin that Medtronic still operates with, at 20%.

While some analysts like the potential for long-term growth for Stryker, others prefer the stability and proven track record of dividend increases and excellence at the top of the industry from Medtronic. Trefis predicts that currently, Medtronic is a better buy while The Motley Fool, Forbes, and The Globe and Mail all see more opportunity with Stryker.

Conclusions

It may seem clear to some, but there is a lack of agreement when it comes down to which stock is the better buy. I believe that both are certainly warranting consideration as buys, but based on my research, as well as the numbers, I believe there may actually be more opportunity in the long-term buying Medtronic.

Medtronic operates with a significantly more appropriate price-to-projected-FCF range, and we can see this thanks to GuruFocus. Their intrinsic value based on this model is significantly closer to the actual traded price than that of Stryker. The consistency with their dividend growth is enticing. The recent advancements in their neurosurgery and cardiovascular device businesses offer potential to right the ship. The could to increased revenue growth in the coming years.

This is not to say Stryker is not a buy. I believe they strongly warrant consideration. I worry about the extreme recent increase to the stock price. I also question how sustainable the revenue growth is year over year. The same GuruFocus model also suggests that the current stock price is significantly higher than their intrinsic value. The 30 years of dividend growth is a sign of stability, but as of now, I would stick with Medtronic if I could only choose one.



Sound investments
don't happen alone

Find your crew, build teams, compete in VS MODE, and identify investment trends in our evergrowing investment ecosystem. You aren't on an island anymore, and our community is here to help you make informed decisions in a complex world.

More Reads
What Materials Should I Invest in?
Image

The materials sector has a wide range of options for different investment strategies. From the speculative nature of rare earth elements to the income strategies around timber production, an investor looking through material stocks has a lot of directions to go.

What will the Metaverse be in five years?
Image

The metaverse is here to stay as the next iteration of the internet. While an older generation may not see why this is the next technology, a younger generation and their parents are seeing the transition.

Virtual Events in the Metaverse
Image

People are more than ever going to live events, but virtual events are seeing an uptick in 2024. With new ad revenue streams in works, virtual events could see a new resurgence.

Metaverse ETFs
Image

While the Metaverse megatrend is looking promising in 2024, the collapse in metaverse investments prices in 2021 and 2022 caused at least three metaverse themed ETFs to liquidate.

Microsoft and the Growth Explosion
Image

Microsoft is an amazing stock for new investors to try. The company has evolved, acquired, and developed a multifaceted set of businesses that are fundamentally driving growth. But for new investors, the barrier to entry is mindset.

AGCO Group - The Pure-Play Farming Stock May be too Hot!
Image

The stock’s intrinsic value clearly shows the cyclicality of the farming industry, independent of AGCO’s own analysis. Agco’s analysis also takes into account the farming industry cyclicality.

Littelfuse - Undervalued Opportunity to Hold for Years
Image

Littelfuse (LFUS) is a component manufacturer currently near a $6 Billion market capitalization. This makes it a small-cap stock, with the potential for further growth in its market segments or to be bought out by a competitor.

Dover Corporation - Great Dividend Stock but Possibly Overpriced
Image

Dover Corporation is a strong investment candidate thanks to its consistent dividend growth, its robust financial performance, and strong capital implementation plan. This stock fits into a strong dividend portfolio well that plans on holding onto stocks for multiple years.

Is BorgWarner a Buy?
Image

BorgWarner fell below $30 today, making it an interesting buy opportunity. The reasons are quite straightforward. The company’s book value per share is $25.36 a share. This means that as long as money continues to be made, BorgWarner becomes undervalued if it nears its book value per share.

Union Pacific is Going Nowhere
Image

Union Pacific is not a buy to start off 2024. Union Pacific is a fine business. There are issues but nothing that is significant enough to believe the company’s intrinsic value will shrink in the next decade.

Dividend Stock Watch List: Lanny’s February 2024 Edition
Image

Dividend investing happens, whether the stock market is up or down, whether the fed raises interest rates or lowers. Inflation or deflation. Banks are failing or being bailed out. Recession, no recession. It’s all about buying dividend income producing stocks – the best source of passive income source on your journey to financial freedom!

January 2024 Stock Considerations
Image

With a new trading year already in full swing it is time, once again, to highlight some of my potential stock purchases for the month.

5 Reasons Not to Use ChatGPT for Financial Advice
Image

It’s truly amazing how far AI has come in such a short period. Not only can it answer most questions, but it can also generate online posts, research papers, and even poetry. However, it still has its limitations.

The Zen Ten - My Top Picks for 2024
Image

I've managed to beat the market by an average of 3.7% per year over the past 10 years. Since I began using this list with clients in 2000, I’ve beaten the market by an average of 9.1% per year.

5 Key Benefits of Long Term Investing in Dividend Stocks
Image

Overall, long-term dividend investing in individual dividend stocks can be a reliable and potentially lucrative way to build wealth and generate passive income over the long term

You Can Be an Excellent DIY Investor
Image

First, save money to invest. That is: don’t spend everything that you make. Next, invest consistently in a reasonable way. That’s it! That’s all it takes to be an excellent DIY investor!

IBM Dividend Safety Analysis
Image

International Business Machines (IBM) is a stock investors love to hate. But after years of underperformance, the share price has recovered to levels last seen in early 2017.

Thermo Fisher Scientific Consistently Creates Shareholder Value
Image

Thermo Fisher’s share price can be volatile. Just before Christmas 2021, for example, TMO’s share traded above $660. At the beginning of March 2022, however, the share price had plummeted to ~$530.

Western Alliance Bank: A Golden Opportunity if we can just Stay Calm
Image

As Western Alliance has dropped from the headlines, the company’s stock has begun to rebound. The stock received a bump after each earnings announcement by reporting the “business as usual”. As we will see, if Western Alliance can continue business as usual, the bank may be a fantastic investment opportunity.

Is Southern Company a Buy?
Image

Southern Company’s price target is neutral at $70. Expect the utility’s price volatility to peak at plus or minus 20% from this price target but not improving too far past this price point for the next few years.

Resources for Publishers
Resources for New Investors
Boosted with BossCoin
Financial Literacy Leaders
user_profile
Tom Hamilton
user_profile
Wise Intelligent
user_profile
Mark Robertson
user_profile
Kevin Matthews II
user_profile
Akeiva Ellis
user_profile
Brendan Dale
user_profile
Kenneth Chavis IV
user_profile
Sharita Humphrey